Outcome predictors for patients with stage II/III gastric cancer who undergo gastrectomy and S-1 adjuvant chemotherapy

Predictors of survival in patients with stage II/III gastric cancer (GC) who received tegafur/gimeracil/oteracil (S-1) adjuvant chemotherapy (ACT) subsequent to gastrectomy were examined. Additionally, the association between dose intensity of S-1 and survival rate was investigated. A total of 62 pa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncol Lett
Autors principals: Fujiwara, Yoshinori, Fukuda, Shuichi, Tsujie, Masanori, Kitani, Kotaro, Inoue, Keisuke, Hayashi, Tomonori, Ishikawa, Hajime, Yukawa, Masao, Inoue, Masatoshi
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2017
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5529945/
https://ncbi.nlm.nih.gov/pubmed/28789388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6286
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars